Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000243110 | SCV000862059 | benign | not specified | 2018-07-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000829367 | SCV000971088 | benign | not provided | 2018-06-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000243110 | SCV001158602 | benign | not specified | 2018-07-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001520674 | SCV001729841 | benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000829367 | SCV005212679 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004529419 | SCV000302539 | benign | FBN1-related disorder | 2019-06-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000243110 | SCV001928033 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000243110 | SCV001976182 | benign | not specified | no assertion criteria provided | clinical testing |